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he Role of Echocardiography and Other
maging Modalities in Patients With Left
entricular Assist Devices
erry D. Estep, MD,* Raymond F. Stainback, MD,† Stephen H. Little, MD,*
uillermo Torre, MD,* William A. Zoghbi, MD*
ouston, Texas
ecent advances in thefieldof left ventricular device support have led toan increaseduseof left ventricular
ssist devices (LVADs) in patients with end stage heart disease. The primary imaging modality to monitor
atientswith LVADs has been echocardiography. The purpose of this review is to highlight the clinical role
f echo and other noninvasive imaging modalities in the assessment of cardiac structure and function in
atients with pulsatile and continuous flow LVADs. In addition, we discuss the role of imaging with
mphasis on echo to detect LVAD dysfunction and device related complications. (J Am Coll Cardiol Img
010;3:1049–64) © 2010 by the American College of Cardiology Foundationf
a
p
p
r
r
v
e
r
a
v
L
L
T
T
C
p
t Tr
ston
scoplthough heart transplantation (HT) is an
deal option for patients with end stage heart
isease, long waiting times have lead to an
ncrease in the use of left ventricular assist
evices (LVADs). LVADs can improve quality
f life and end organ function in patients with
efractory heart failure (1). Although echocar-
iography (echo) has become the primary im-
ging modality to facilitate pre-LVAD man-
gement and for post-implantation monitoring
f patients with all types of LVADs, there are
nly limited published descriptions for these
pplications. Echo is an ideal modality to
onitor patients after LVAD implantation
ecause it is noninvasive, widely available,
nd can be performed at the bedside. Ac-
ordingly, the purpose of this review is to
ighlight the evolving clinical role of echo in
he assessment of ventricular structure and
rom the *Department of Cardiology (Heart Failure and Hear
nstitute; The Methodist DeBakey Heart and Vascular Center, Hou
dult Echocardiography, Texas Heart Institute at St. Luke’s Epi
eported that they have no relationships to disclose.anuscript received May 12, 2010; revised manuscript received July 8unction, hemodynamics, valvular function,
nd myocardial recovery in patients with
ulsatile and continuous-flow surgically im-
lanted LVADs. In addition, we discuss the
ole of echo to detect LVAD dysfunction and
elated complications as well as other nonin-
asive imaging modalities when the echo
xamination is limited. We will also provide
ecommendations to guide image acquisition
nd reporting to facilitate continued nonin-
asive monitoring of patients supported by
VADs.
VAD Types and Function
he different types of LVADs are listed in
able 1. The HeartMate XVE (Thoratec
orp., Pleasanton, California), a pulsatile
ump, can be operated in either a fixed-rate
ansplantation) and the Cardiovascular Imaging
, Texas; and the †Department of Cardiology and
al Hospital, Houston, Texas. The authors have, 2010, accepted July 20, 2010.
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TR tricuspid regurgitation
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1050partial support) or automatic mode (full support)
nd can produce a maximum stroke volume of 83
l at varying rates (from 50 to 120 beats/min),
esulting in flow rates from 4 to 10 l/min.
ulsatile LVADs do not routinely require Cou-
adin use in contrast to the continuous-flow
VADs, which may account for their continued,
lbeit less common use. Second- and third-
eneration continuous (axial and centrifugal) flow
umps offer several advantages including smaller
ize, less noise, and greater long-term mechanical
eliability. The HeartMate II pump (Thoratec
orp.) is the only continuous-flow pump currently
approved as a bridge to HT and as destina-
tion therapy. This device has a pump im-
plant volume of 63 ml and can be operated
at a pump speed between 8,000 to 12,000
revolutions/min (RPM), generating flow
rates up to 10 l/min (2).
Left Ventricular (LV) Structure and
FunctionWith LVAD Support
Assessment of linear dimensions. LVADs
provide excellent unloading of the left ven-
tricle (LV) and significant reduction in LV
dimensions and improvement in LV func-
tion. For pulsatile LVADs, device filling and
ejection is not timed with the native cardiac
cycle and this asynchrony explains why the
greatest left ventricular end-diastolic diame-
ter (LVEDd) may not necessarily coincide
with end diastole as defined by the electro-
cardiogram (Fig. 1). For continuous-flow
pumps, in contrast, there is a constant de-
gree of hemodynamic support as reflected
by the consistent LV internal dimensional
changes during the cardiac cycle (Fig. 2A).
The LVEDd, which is dependent on pre-
load and afterload, will be influenced by the
ump speed. For continuous-flow LVADs, measure-
ents of LV end-systolic and -diastolic diameters are
ess problematic (Fig. 2B). For pulsatile devices, we
ecommend measuring the largest LVEDd at the end
f mechanical diastole, just after mitral valve (MV)
losure and the smallest LV end-systolic diameter. In
omparison to measuring LV linear dimensions from
he parasternal views, it may be difficult to accurately
easure LV volumes using standard apical views due
o the apical inflow cannula and associated shadowing
r attenuation artifact.
ssessment of function. The clinical importance of
t
-
ionollowing LV systolic function relates to screening aor myocardial recovery. Most studies report calcu-
ating left ventricular ejection fraction (LVEF) us-
ng either the method of disks from the apical view
r the fractional shortening method from the
arasternal long- and/or short-axis views (3–6).
ither approach may have limitations secondary to
arked paradoxical septal motion, asynchronous
upport (pulsatile LVAD), or difficulties of imaging
rom the apical window. An alternative method is
hat of the multiple diameter method in 2 views,
ith the assumption that the apex is akinetic (7).
alby et al. (8) demonstrated in patients with
ulsatile LVADs that the most representative frac-
ional shortening assessment of intrinsic LV perfor-
ance occurred when the posterior wall motion was
reatest and coordinated with septal movement.
his type of analysis requires imaging several car-
iac cycles. In technically difficult cases, in order to
valuate ventricular function, contrast echocardiog-
aphy may be used to enhance endocardial visual-
zation or, alternatively, multiple-gated acquisition
adionuclide imaging (9).
V Structure and FunctionWith LVAD Support
he beneficial effect of LVADs on the right ven-
ricle (RV) appears secondary to a decrease in
ulmonary artery pressure. Right heart dysfunction
s, however, a significant concern after LVAD
mplantation and contributes to post-operative
orbidity and mortality (2). Lam et al. (10) re-
orted that a comprehensive right heart exam can
e obtained in 80% of LVAD-echo studies with
ood intraobserver and interobserver variability in
he assessment of RV functional parameters. When
evere RV failure occurs, the RV is usually enlarged
nd significant tricuspid regurgitation (TR) may
evelop as a consequence of RV and tricuspid
nnular dilation and severe leftward shifting of the
nterventricular septum. Associated echo features of
V failure include parameters of elevated right
trial pressure (as judged by interatrial septal mo-
ion, tricuspid diastolic inflow, inferior vena cava
ize, and hepatic flow pattern) and a small LV
hamber or collapse of the LV around the inflow
annula.
Predicting RV function after LVAD implanta-
ion remains a challenge. The LVAD Working
roup (5) observed that LVEF decreases over time
n the majority of patients with pulsatile LVADs in
ontrast to consistent improvement in RV systolic
unction measured by right ventricular fractionalB B R E V I A T I O N S
N D A C R O N YM S
R aortic regurgitation
V aortic valve
O cardiac output
T computed tomography
cho echocardiography
T heart transplantation
V left ventricle
VAD left ventricular assis
evice
VEDd left ventricular end
iastolic diameter
VEF left ventricular eject
raction
Rmitral regurgitation
Vmitral valve
VR pulmonary vascular
esistance
PM revolutions/min
V right ventricle
VFAC right ventricular
ractional area changerea change (RVFAC). However, 2 groups found
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1051hat in a small number of continuous-flow LVAD
atients (n 41), there was significant variability in
V function as measured by RVFAC or tricuspid
nnular plane systolic excursion (10,11). Impor-
antly, Maeder et al. (11) demonstrated that
mproved global RV function after LVAD was
ssociated with improved renal function and re-
uced mortality. Similarly, Lam et al. (10) dem-
nstrated that patients with a greater than 10%
eduction in RVFAC at 1 month compared to
aseline had worse quality of life and lower
xercise capacity compared with patients without
significant change in RVFAC. These findings
re consistent with those reported by Simon et al.
12) where post-operative RV function predicted
xercise performance as assessed by maximum
xygen consumption.
emodynamics
n patients with LVADs, total systemic or RV
Table 1. Adult LVAD Types
Surgical LVAD Types Pump Design
First-generation LVADs
HeartMate XVE*
Novacor LVAS*
Thoratec LVAD*
Pulsatile ﬂow pump
Second-generation LVADs
HeartMate II*
MicroMed DeBakey pump†
Jarvik FlowMaker†
Continuous ﬂow
(Axial ﬂow pump)
Third-generation LVADs
VentrAssist LVAS†
HeartWare LVAD†
DuraHeart LVAS†
Levacor VAD†
Continuous ﬂow
(Centrifugal ﬂow pump)
*Clinically available. †Investigational in the U.S. Thoratec Vented Electric (VE) H
Corp., Oakland, California); Thoratec LVAD (Thoratec Corp.); HeartMate II (Thorate
FlowMaker (Jarvik Heart Inc., New York, New York); VentrAssist LVAS (Ventraco
(Terumo Heart Inc., Ann Arbor, Michigan); Levacor (World Heart). Device illustr
parallel with the impellar axis); centrifugal ﬂow (blood ejected at a right angle to
aorta. Device illustrations reprinted, with permission, from Thoratec Corporatio
LV  left ventricular; LVAD  left ventricular assist device; LVAS  left ventriardiac output (CO) is the sum of intrinsic LVFigure 1. Asynchronous Pulsatile LVAD Support
M-mode recording illustrates signiﬁcant difference in left ventricular end-
diastolic diameter and fractional shortening because of asynchronous pulsa-
tile left ventricular assist device support: smaller values when posterior wall
motion is least and septal wall motion is incoordinate (interrupted arrows)
in contrast to when the posterior wall motion is the greatest along with
coordinated septal wall motion (continuous arrow). Adapted, with permis-Device Illustration
eart Mate XVE (Thoratec Corp., Pleasanton, California); Novacor LVAS (World Heart
c Corp.); MicroMed DeBakey pump (MicroMed Technologies, Houston, Texas); Jarvik
r, Sydney, Australia); HeartWare (HeartWare Inc., Miami Lakes, Florida); DuraHeart
ations: pulsatile (pusher plate pump in housing container); axial ﬂow (blood ﬂows
the impellar blades). Blood ﬂow direction is from LV apex to device to the ascending
n.sion, from Dalby et al. (8). LVAD  left ventricular assist device.
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1052utput through the aortic valve (AV) and that of the
VAD. Both pulsatile and continuous-flow
VADs are associated with a decrease in normal
V opening; the contribution of intrinsic LV sys-
olic function is reflected by the duration and
requency of AV opening (13). Intermittent or
ariable AV opening is associated with variable
eft-sided stroke volumes. Using standard Dopp-
er methods, investigators have examined RV
ardiac output using pulsed-wave Doppler in the
V outflow tract (Fig. 3) (10,13,14). In patients
ith persistent AV closure seen with higher
VAD pump speeds and/or very poor native LV
ystolic function, the RV cardiac output repre-
ents the complete flow generated by the pump.
An indirect estimation of pump flow when there
s at least partial AV opening is RV cardiac output
inus LV outflow tract CO (13,14). With the
xception of the MicroMed DeBakey pump
MicroMed Technology, Inc., Houston, Texas), all
LV Dimension Assessment With Continuous-Flow Pumps
e recording illustrates synchronous LV-LVAD relationship. Consistent
tinuous yellow arrow) and end-systolic dimensions (interrupted
w) are seen albeit with paradoxical septal motion. (B) LVEDd mea-
ntimeters from the septum to posterior wall. Yellow * highlights the
of the inﬂow cannula. LVEDd  left ventricular end-diastolic diame-
revolutions per minute; other abbreviation as in Figure 1.ump console–reported flows are estimates based on oump power consumption. Therefore, it is our prac-
ice to measure and report estimated right-sided CO
long with the degree of AV opening by M-mode
normal, partial, intermittent, or complete AV clo-
ure) for a qualitative estimate of native aortic
utflow. Increasing the pump speed in continuous-
ow pumps has been associated with an increase in
V cardiac output, predominately by increasing
reload (13). Another potential noninvasive alter-
ative to estimate systemic CO is dynamic com-
uted tomography (CT). Raman et al. (15) dem-
nstrated the feasibility of using signal intensity
ersus time recordings with contrast-enhanced CT
o estimate CO with good agreement when com-
ared with invasive thermodilution measurements
correlation coefficient of 0.74). However, addi-
ional and larger validation studies are needed.
Investigators have shown that patients with
ulsatile-type LVADs in comparison to those with
he DeBakey pump had greater reductions in the
itral E/A ratio and greater prolongation of decel-
ration time (16). One must consider, however, that
igher pump speed settings with continuous-flow
umps may also be associated with greater reduc-
ions in LV filling pressure with similar affects on
V inflow parameters (Fig. 4). The accuracy of
cho to detect persistently elevated LV filling pres-
ure in patients with continuous flow LVADs is
urrently under investigation.
ulmonary Hypertension
erial Doppler echo assessment of pulmonary artery
ressure is important after LVAD implantation.
ulmonary hypertension with a presumed “fixed”
omponent (elevated transpulmonary gradient 15
m Hg or elevated pulmonary vascular resistance
4 Wood units) is highly associated with RV
ailure and reduced survival after HT (17). LVAD
upport offers a suitable alternative in this patient
opulation and may result in pulmonary pressure
ormalization, permitting transplant candidacy at a
ater date (18).
Doppler markers of pulmonary artery pressures
ave been shown to significantly decrease with
VAD support. These include the peak velocity of
he TR jet (proportional to pulmonary artery sys-
olic pressure as shown in Figure 5), the pulmonary
ein acceleration time (inversely proportional to
ean pulmonary artery pressure), and estimated
ulmonary vascular resistance (PVR) using the
bbas formula [(maximum tricuspid velocity/RVFigure 2.
(A) M-mod
LVEDd (con
yellow arro
sured in ce
positioningutflow tract time-velocity integral)  10  0.16]
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105310,16,19). In this regard, echo is the first line exam
o screen for pulmonary hypertension in patients
upported by LVADs, especially for patients where
nticoagulation is required and invasive testing is
ess attractive. In addition, Lam et al. (10) dem-
nstrated the clinical importance of measuring
Figure 3. Systemic Cardiac Output Assessment
(A) Right ventricular outﬂow tract diameter assessment. (B) Time ve
tract. The calculated stroke volume (86 cc) at a heart rate of 80 bea
tricular outﬂow tract diameter; SV  stroke volume; TVI  time vel
Figure 4. Mitral Valve Inﬂow Doppler Pattern at Various Contin
The E-wave velocity, E/A ratio, and pulmonary capillary wedge pres
lar assist device pump speed from 8,000 to 11,000 revolutions/min
tricular assist device. A  late peak mitral valve inﬂow velocity; E 
wedge pressure; other abbreviations as in Figures 1 and 2.VR in patients supported by the HeartMate II
Thoratec Corp.). Those who had 50% reduc-
ions in PVR 1 month after LVAD placement
ad better quality of life and higher exercise
apacity at 6 months compared with patients with
ower reductions in PVR (10).
ty integral by pulsed Doppler in the right ventricular outﬂow
in equates to a cardiac output of 6.8 l/min. RVOTd  right ven-
integral.
s-Flow LVAD Pump Speed Settings
(measured simultaneously) decrease with increasing left ventricu-
o D) in a patient with the HeartMate II (Thoratec Corp.) left ven-
ly peak mitral valve inﬂow velocity; PCWP  pulmonary capillaryloci
ts/muou
sure
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1054alvular AssessmentWith LVAD Support
itral regurgitation (MR) is often significantly
educed after LVAD placement secondary to re-
uced LV size, filling pressures, and improved
oaptation of the MV leaflets (20). Given that
ulsatile LVADs operate in a full-to-empty mode,
he reduction in degree of MR appears greater with
ulsatile compared with continuous-flow LVADs
16,21). Persistence of significant MR after contin-
ous LVAD placement may indicate inadequate
V decompression. In our experience, changing the
ump speed setting with real-time echo imaging
an be used to evaluate the effect of various pump
peeds on LV dimensions, MV inflow parameters,
nd severity of MR.
Most patients supported by pulsatile LVADs
ave significant reductions in pulmonary pressures
nd TR (20,22). With continuous-flow pumps,
igher pump speed settings can potentially increase
he severity of TR because of increased RV preload
13) and distortion of the tricuspid valve annulus
mediated by shifting of the interventricular septum
nd subsequent papillary muscle distortion). Real-
ime echo can be used to adjust the pump speed
etting (i.e., decrease the RPMs) to produce a more
ightward shift of the interventricular septum and a
ecrease in the severity of TR (23).
In a normally functioning pulsatile pump, AV
pening is infrequent (24). Aortic valve opening
uring continuous-flow LVAD support depends on
he balance between native LV systolic function,
he LVAD pump speed, the degree of LV unload-
Pulmonary Pressure Assessment During LVAD Support
systolic pulmonary artery pressure obtained from the peak tricus-
itation jet velocity using continuous-wave Doppler and the modi-
ulli equation. PA  pulmonary artery; RA  right atrium; RVSP 
icular systolic pressure; v  peak tricuspid regurgitation velocity;
eviations as in Figures 1 and 4.ng and preload and afterload pressures. Myers et al. d25) reported that the AV was open 97% of the time
t a low Jarvik pump speed (8,000 RPM) compared
ith only 22% of the time at the highest pump
peed. The clinical implications of reduced AV
ulsatility or persistent AV closure are as follows: 1)
utomated blood pressure cuff measurements are
nreliable given the decrease in pulse pressure
ithin the arterial circulation; 2) aortic regurgita-
ion (AR) may worsen and can be seen throughout
he cardiac cycle; 3) complete AV closure has been
ssociated with thrombus formation in the aortic
oot; and 4) complete AV closure at low pump
ettings may indicate a high level of LVAD depen-
ency. The risk of developing AR is increased
uring LVAD support because the continuously
losed AV is exposed to a higher pressure gradient
20). The incidence of AR after LVAD placement
n patients without previous aortic insufficiency
owever is low (24). Both AV motion and AR can
e analyzed by echo (Fig. 6). If clinically significant
R is suspected, it can be confirmed by observing
educed flows across the RV outflow tract despite
ormal inflow/outflow cannula Doppler profiles, in
ddition to significant regurgitation parameters by
cho color Doppler.
yocardial Recovery
he LVAD Working Group demonstrated that
VEF improved and LVEDd decreased early after
VAD implantation. After longer duration of
VAD support (4 months), recurrent LV dilation
nd a decline in LVEF was observed (5). Most
atients, however, experienced an improvement in
unctional capacity despite seemingly adverse serial
hanges in LV size and contractility. Myocardial
ecovery, on the other hand, can occur in a small
ercentage of patients supported by LVADs (5% to
1%) (4,5). Data to assess the potential for recovery
f function and possible LVAD explantation are,
owever, sparse. In the presence of signs of LV
ecovery, a clinical profile that may prompt consid-
ration of possible elective LVAD explantation is
hat of younger age, shorter duration of heart
ailure, and nonischemic etiology (26,27).
Pharmacologic and exercise stress echo during
ff-pump, partial, and full LVAD support have
een examined to detect recovery (Table 2)
3,5,26,27). The LVAD Working Group used
obutamine-stress echo to screen for recovery in
atients with reduced LVAD support and an
VEF 40% (5). When cardiac recovery wasFigure 5.
Estimated
pid regurg
ﬁed Berno
right ventrefined by an LVEF 40% during exercise echo,
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1055rue long-term clinical stability was less likely as
emonstrated in 2 reports where collectively 6 of 8
atients (75%) either died or developed recurrent
eart failure after LVAD removal requiring LVAD
eimplantation or HT within 3 years of follow-up
4,28). In contrast, Dandel et al. (26) demonstrated
hat the highest predictive off-pump resting echo
alues for long-term (3 years) post-LVAD car-
iac stability were obtained for LVEF of 45%
ombined with either a LVEDd 55 mm or a
elative wall thickness 0.38 (26). In this cohort,
ff-pump LVEF 40% alone showed low predict-
bility for cardiac stability after LVAD removal.
hese data support the notion that measures of wall
tress and LV size, in addition to LVEF, are
mportant. Although there is no uniformly accepted
VAD echo weaning protocol, the decision for
evice explantation is usually based on clinical
tability and invasive hemodynamics in addition to
cho parameters of cardiac structure and function.
A novel surrogate of LV systolic performance in
atients supported by LVADs is based on AV
pening. LV contractility can increase over the
ourse of LVAD support, with an associated in-
rease in the frequency/duration of AV opening.
ancini et al. (4) used echo to quantitate AV
pening in pulsatile LVADs at rest and at peak
xercise. With reduced LVAD support in 18 pa-
ients evaluated for potential myocardial recovery,
V opening was present in almost all patients (4).
n patients supported by continuous-flow devices,
ncreasing device support can unload the LV to a
oint where LV systolic pressure is less than mean
rterial pressure. This causes continuous AV clo-
ure. The speed setting at which this occurs is
elated in part to underlying LV contractility (29).
he ability to maintain AV opening above relatively
igh levels of continuous pump support (i.e., Heart-
ate II [Thoratec Corp.] pump speed 10,000
PM vs. 9,000 RPM) was noted in patients who
ad successful elective LVAD explantation (30).
hese retrospective observations are limited by
mall sample size. Additional studies are needed to
ncorporate AV opening/LV outflow tract flow
ssessment in addition to standard echo parameters
o identify patients with sufficient LV recovery who
enefit from elective LVAD explantation.
Lastly, there is a paucity of literature evaluating
V recovery in patients supported by continuous-
ow pumps. Completely stopping or lowering rotor
ump speed in these patients may lead to retrograde flow
nto the LV and influence the assessment of LV size and
unction. Therefore, the observation of reducing the tump speed to a rate where there is no forward or back
ow through the inflow or outflow cannula (i.e., Heart-
ate II [Thoratec Corp.] pump speed 6,000 RPM)
sing Doppler echo may be similar to off-pump pulsatile,
eaning LVAD echo studies (14,26,31). However, fur-
Figure 6. Various Degrees of Aortic Valve Opening With Contin
Support
M-mode illustration of various patterns of aortic valve opening (arr
different patients with HeartMate II left ventricular assist devices (Th
Corp.). (A) Normal, consistent aortic valve opening. (B) Intermittent
able partial aortic valve opening and closure. (C) Complete aortic v
sure (no opening).uous-Flow
ows) in 3
oratec
and vari-
alve clo-her prospective studies are needed.
abbreviations as in Table 1.
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1056Figure 7. Spectral Doppler Examination of LVAD Cannulas
Illustration of normal inﬂow and outﬂow cannula velocity patterns for pulsatile and continuous ﬂow left ventricular assist devices. Red
and green arrows represent the pump-ﬁlling and ejection time periods, respectively. Standard apical (inﬂow) and right parasternal axisTable 2. Examined Echo Parameters Associated With Myocardial Recovery
Author, Year (Ref. #)
Total
Patients LVAD Type Echo Protocol
Echo Parameters of Patients
Deemed Favorable Versus
Unfavorable for LVAD Explant p Value
Outcome Associated With
Favorable
Response
Khan et al., 2003 (3) 16 100% pulsatile
pumps
Dobutamine stress
echo*
LVEF: 48 9% vs. 27 11%
LVEDd: 4.68 1.1 cm vs.
5.48 0.5 cm
LVSD: 3.43 0.9 cm vs. 4.63
0.6 cm
0.01
0.3
0.001
6 of 9 favorable responders
survived more than 12
months following LVAD
explant
Maybaum et al.,
2007 (5)
15 98% pulsatile
pumps
Dobutamine stress
echo*
LVEF: 60 10% vs. 40 13% 0.05 6 favorable responders
deﬁne the LVAD explant
group
George et al., 2007 (27) 22 100% pulsatile
pumps
Off-pump echo† LVEF: 63.9 6.9% vs. 30 17.9%
LVEDd: 5.65 0.82 cm vs.
6.0 1.05 cm
LVSD: 4.0 0.66 cm vs.
5.32 1.23 cm
0.05
NS
0.05
14 of 16 favorable
responders
demonstrated clinical
stability following LVAD
explant
Dandel et al., 2008 (26) 27 88% pulsatile
pumps
Off-pump echo‡ LVEF: 48.9 1.0% vs. 42.6 1.6%
LVEF: change: –4.2 1.2% vs.
–16.2 4.5%§
LVEDd: 4.9 1.1 cm vs.
5.6 1.2 cm
LVEDd change: 5.0 1.5% vs.
19.9 4.5%§
RWT: 0.41 0.01 vs. 0.33 0.01
RWT change: –7.1 0.6 vs.
–16.6 2.0%
LV sphericity index: 0.65 0.02
vs. 0.72 0.02¶
0.01
0.001
0.01
0.001
0.001
0.001
0.04
15 favorable responders
compared with 12
explanted
nonresponders
demonstrated clinical
stability 5 years
following LVAD explant
*Dobutamine stress echocardiography during LVAD weaning with echo parameters obtained at peak dobutamine. †Off-pump echo with parameters obtained 15 min after pneumatic hand
pumping. ‡Off-pump echo with the maximum echo parameters obtained during repeated off-pump trials performed over several days. §LVEF and LVEDd change are the percentages of best
value recorded during repeated-off pump trials. RWT change is the percentage of change recorded during repeated off-pump trials. ¶LV sphericity index is deﬁned as the LV short-/long-axis
ratio.
LVEDd left ventricular end-diastolic diameter; LVEF left ventricular ejection fraction; LVSD left ventricular end-systolic diameter; NS not signiﬁcant; RWT relative wall thickness; other(outﬂow) views used. CW  continuous wave Doppler; PW  pulsed wave Doppler; other abbreviations as in Figure 1.
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1057etection of LVADDysfunction and
ost-Implant Complications
ormal LVAD cannula Doppler ﬁndings. The inflow
nd outflow cannula and associated flows are always
efined relative to the device. Apical inflow and
utflow cannula position, flow type and direction,
nd the velocity flow pattern can be assessed using
-dimensional, color and spectral Doppler echo in
he majority of cases. Horton et al. (24) demon-
trated that the inflow cannula can be imaged from
he apical views in 96% and the outflow conduit
rom the right parasternal view in 98% of transtho-
acic echos. In our experience, these can be imaged
n the vast majority (80%) of cases using standard
nd off-axis views. For pulsatile LVADs, peak
pical inflow velocities are usually below 2.5 m/s
ith a peak outflow cannula velocity 2 m/s
Figure 8. Effect of Imaging Windows on Doppler Recordings of
Normal continuous left ventricular assist device apical inﬂow Doppl
Standard 4-chamber apical view with nonaliasing color Doppler api
directed toward the apical transducer. (B) Off-axis 2-chamber apical
Note the Doppler signal directed away from the transducer with no
tion of normal apical inﬂow (yellow arrow), similar to B.22,24). In comparison, continuous-flow LVADs
ave normal, consistently phasic, slightly pulsatile,
ow-velocity inflow and outflow patterns, with peak
elocities 2.0 m/s and typically 1.5 m/s (Fig. 7)
13,32). Normal apical inflow appears as nonturbu-
ent flow toward the apical transthoracic transducer.
owever, with off-axis imaging, the apparent di-
ection of normal flow relative to the transducer
ay vary (Fig. 8).
bnormal LVAD cannula Doppler ﬁndings. LVAD
ysfunction may be indicated by built-in alarm
ystems that sense low pump rates caused by various
echanisms of cannula obstruction. These include:
annula thrombus, partial inlet occlusion by adja-
ent myocardial trabeculations, cannula angulation
nto the myocardium or other cannula malposition
aused by LV underfilling, and inlet or outlet
inking (23,33). For pulsatile pumps, a peak inflow
Apical Inﬂow Cannula
ptimized for window of acquisition in 3 different patients. (A)
nﬂow (red arrow) and low peak velocity (1.5 m/s) with ﬂow
w illustration of normal apical inﬂow characteristics (white arrow).
l ﬂow relative to the device. (C) Parasternal long-axis view illustra-the
er o
cal i
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1058elocity 2.5 m/s or intermittent interruptions of
he usual laminar cannula inflow is indicative of
nflow cannula obstruction (22,24). In contrast, for
ontinuous-flow pumps, a peak inflow velocity 2
/s with associated turbulent flow may represent
ither inflow cannula obstruction, malposition, or
mproved LV systolic function (Fig. 9) (32,33). For
ulsatile LVADs, significant inflow valve regurgita-
ion secondary to mechanical failure of the inflow
Figure 9. Examples of Apical Inﬂow Abnormalities Detected by
Patient #1: HeartMate XVE (Thoratec Corp.) inﬂow cannula obstruct
elevated continuous wave Doppler peak device ﬁlling velocity 4 m
atec Corp.) dynamic inﬂow cannula obstruction due to overly decom
apical parasternal long-axis view with turbulent ﬂow (yellow *) and
approaching 2 m/s. Patient #3: VentrAssist (Ventracor) inﬂow cannu
continuous wave Doppler peak inﬂow velocities 4 m/s (green arr
tricular ejection into the device after myocardial recovery. Off-axis a
m/s (white arrow). LV  left ventricular; other abbreviations as in F
Figure 10. Detection of Inﬂow Valve Regurgitation
(A) Color Doppler showing inﬂow valve regurgitation. (B) Pulsed Do
left ventricular systole and increased ﬂow during left ventricular dia
valve regurgitation; other abbreviations as in Figure 9.alve is the most common cause of LVAD dysfunc-
ion (Fig. 10). Horton et al. (24) demonstrated that a
eak outflow velocity 1.8 m/s is associated with an
4% specificity and 89% sensitivity to detect signifi-
ant inflow valve regurgitation. Because continuous-
ow LVADs are valveless, diastolic regurgitation
hrough the outflow graft from the aorta into the LV
econdary to pump failure is associated with an ab-
ormal retrograde apical flow pattern (Fig. 11).
sthoracic Echo
rom malposition. Modiﬁed apical parasternal long-axis view with
(red arrow) (normally 2.5 m/s). Patient #2: HeartMate II (Thor-
ssed left ventricle with septum abutting device inﬂow. Modiﬁed
tinuous wave Doppler peak inﬂow velocity intermittently
bstruction from malposition (Fig. 12). Apical view with increased
Patient #4: HeartMate II (Thoratec Corp.) hyperdynamic left ven-
l view with continuous wave Doppler peak inﬂow velocity 4
e 4.
er showing attenuation of inﬂow valve regurgitation ﬂow during
e. Adapted, with permission, from Horton et al. (24). IVR  inﬂowTran
ion f
/s
pre
con
la o
ow).
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1059ther LVAD dysfunction/related complications. In ad-
ition to thrombosis of the LVAD cannula, several
ther complications may occur early and late after
mplantation that can be detected by echo and are
isted in Table 3. Cannula malposition may cause
ow-flow LVAD alarms, ventricular arrhythmias, or a
linically low CO state. Increasingly, with newer
Figure 11. Echo Findings With Continuous-Flow Pump Failure
Left ventricular assist device on: Parasternal long-axis view with min
velocity ﬂow pattern (yellow arrows). Left ventricular assist device
regurgitant inﬂow (yellow *), increased mitral regurgitation (red arr
Doppler standard apical view. Abbreviations as in Figure 4.
Table 3. LVAD Dysfunction and Post-Implant Complications Det
Pericardial effusion with or without cardiac tamponade
RV failure (increased RV size, decreased RV systolic function, increas
Inadequate LV ﬁlling (small LV dimensions)
LVAD-induced ventricular ectopy or tachycardia (underﬁlled LV and
LVAD-related continuous aortic insufﬁciency (aortic regurgitation th
Intracardiac thrombus (including right and left atrial, LV apical, and
Pulsatile pump inﬂow valve regurgitation (apical inﬂow cannula tur
frequent opening of the AV, and reduced outﬂow graft ﬂow 1.
Pulsatile pump apical inﬂow obstruction (intermittent interruption o
inﬂow velocities 2.5 m/s and color ﬂow aliasing at the cannula
Continuous pump apical inﬂow abnormality due to inﬂow cannula
aliased ﬂow at the cannula oriﬁce with a peak Doppler velocity 
Cannula kinking or complete thrombosis (loss of Doppler signal in
Hypertensive emergency, continuous ﬂow pump (minimal AV open
Impeller cessation, continuous ﬂow pump (dilated LV, acute reversa
and decreased RV outﬂow tract stroke volume)AV  aortic valve; LV  left ventricle; MR  mitral regurgitation; RV  right ventrichird-generation device shapes or because of specific
ody habitus, the inflow cannula may be placed in an
nferior LV approach. This may necessitate modified
-dimensional and Doppler imaging from the
arasternal views as opposed to the apical view. Can-
ula/graft malposition or distortion may also be sus-
ected on routine chest radiography or detected by
l mitral regurgitation (white arrow) and a normal apical inﬂow
ped: 2 months later, VentrAssist (Ventracor) pump failure with
, and reversal of apical inﬂow (yellow arrows) using spectral
d by Echo
ight atrial pressure, and increased tricuspid regurgitation)
chanical impact with septum)
hout cardiac diastole and systole)
tic root thrombus)
nt ﬂow detected by color Doppler during LVAD ejection, dilated LV,
/s)
ual laminar LVAD diastolic inﬂow using pulsed-wave Doppler with
ce)
ruction, malposition, or hyperdynamic apical LV function (color Dopp
/s)
cho views and loss of RV outﬂow tract stroke volume with speed cha
dilated LV, worsening MR, and peak outﬂow cannula velocity 2 m/
apical inﬂow ﬂow direction using spectral or color Doppler, worseninima
stop
ow)ecte
ed r
me
roug
aor
bule
8 m
f us
oriﬁ
obst ler high-velocity
2 m
all e nge)
ing, s)
l of g MR,le; other abbreviations as in Table 1.
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1060Figure 12. Cardiac CT Illustration of LVAD
(A) VentrAssist (Ventracor) apical inﬂow cannula visualization (malposition with the cannula directed toward the distal left ventricular free
wall with no apical inﬂow thrombus seen). Note the nonmetallic inﬂow cannula extension (red arrow). (B) Contrast computed tomography
showing a patent, nonobstructed outﬂow cannula/graft (red arrow). Courtesy of Su Min Chang, MD. (C) Three-dimensional volume rendering
of contrast-enhanced electrocardiograph-gated cardiac computed tomography demonstrating both the HeartMate II inﬂow and outﬂow cannu-
las. By multiplanar reformation (not shown), the inﬂow cannula is directed toward the distal interventricular septum. See Online Video 1. Cour-
tesy of Benjamin Y. Cheong, MD. CT  computed tomography; RV  right ventricle; other abbreviations as in Figures 1 and 9.Figure 13. Echo Detection of Thrombus in Patients With Continuous-Flow LVADs
(A) Aortic root thrombus (yellow arrow). (B) Coronary cusp thrombus (red arrow). (C) Visualized apical inﬂow cannula (yellow *) using
contrast echo. (D) Apical thrombus (white arrow) seen with contrast echo adjacent to but not obstructing the inﬂow cannula. Abbrevia-
tions as in Figure 1.
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1061atheter-based techniques (34). A potentially robust
maging modality to image LVAD cannulas is cardiac
T. In comparison to echo, cardiac CT is not limited
y acoustic windows and lacks acoustic shadowing.
urthermore, the LVAD cannulas can be interrogated
rom multiple views, permitting direct visualization
Fig. 12). Raman et al. (35) demonstrated that the
ensitivity and specificity of cardiac CT to detect
annula thrombosis or inflow cannula malposition
sing intraoperative findings as the gold standard was
5% and 100%, respectively. A limitation of cardiac
T, however, relates to the radiation exposure and the
isk of nephrotoxicity from iodinated contrast.
Rarely, LVAD support is associated with aortic
oot thrombosis secondary to blood stasis in the
etting of prolonged AV closure. In persistent closed
Vs, laminated thrombus may form more commonly
r more prominently in the noncoronary cusp, pre-
umably due to lack of coronary artery runoff. Throm-
us can also form in the cardiac apex. Echo, especially
ith the use of contrast, can aid in the identification of
pical thrombus, which can be difficult to detect in the
resence of an apical inflow cannula (Fig. 13). Echo
an also identify circulating air microcavitations. Pul-
atile pumps may produce negative inflow pressures
hen functioning in a low pressure environment, such
s systemic hypotension in the operating room, or
fter placement of the inflow cannula in the left atrium
36,37). A small leak in the negative pressure circuit
xposed to air may produce catastrophic air embolism,
hich can be detected by ultrasound.
Both pulsatile and continuous flow LVADs have
een associated with commissural fusion of the AV
38,39). Although the true incidence of AV commis-
ural fusion and its determining factors are unknown,
recent study has suggested that AV commissural
usion may be related to the presence of mild-to-
oderate continuous AR (Fig. 14) (39). Other com-
lications include kinking, thrombus, or endocarditis
t the outflow cannula–ascending aorta anastomotic
ite. A modified parasternal transthoracic echo ap-
roach can often follow the course of the outlet
onduit up the anterior chest to the level of the aortic
nastomosis as well, serving as a routine LVAD view
Fig. 15A). Transesophageal echo may be useful in
isualizing this area from the transverse aorta level or
hrough the level of the right pulmonary artery (Fig.
5B). Transesophageal echo can also be used in
ritically ill patients in the intensive care units, when
n atrial level right-to-left shunt or a cardiac source of
mbolus following LVAD is suspected.
maging artifacts. As previously alluded to, the inflow
annula produces a characteristic downfield signalttenuation artifact that can hamper endocardial def-
nition. Doppler artifacts seem to be related to the
roximity of the moving impeller mechanism to the
nflow cannula. Such devices include the Jarvik
Figure 14. LVAD-Associated Continuous Aortic Regurgitation
Color M-mode illustrating continuous aortic regurgitation (seen thro
systole and diastole). See Online Video 2. Abbreviation as in Figure
Figure 15. Outﬂow Cannula Visualization by 2-Dimensional Ech
Transthoracic echo using the low right parasternal view (A) and tra
ageal echo (B) at the level of the right pulmonary artery to visualiz
outﬂow cannula. Ao  ascending aorta; C  outﬂow cannula; RPAughout
1.o
nsesoph-
e the
 rightpulmonary artery.
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1062VAD (Jarvik Heart Inc., New York, New York), an
mpeller mechanism intrinsic to the inlet cannula, and
he DuraHeart (Terumo Heart Inc., Ann Arbor,
ichigan) and HeartWare (HeartWare Inc., Fram-
ngham, Massachusetts), centrifugal pump housings
hat come in contact with inflow cannula. When the
nflow cannula is within the imaging sector, Doppler
ignals are severely degraded, presumably due to the
roduction of ultrasound frequencies from the device
Fig. 16). However, in most cases, this can be “worked
round” by modified views to exclude actual images of
he inflow cannula.
maging acquisition/reporting. In our practice, the
omprehensive LVAD exam consists of a standard
cho with attention to ventricular dimensions, AV
unction, and routine inflow and outflow cannula
nterrogation as noted in Table 4. We obtain a
aseline surveillance transthoracic echo 2 weeks
rtifact With Newer Continuous-Flow Devices
r artifact when the color sector included the HeartWare apical
arrow). revolutions/min; other abbreviations as in Tables 1 and 3.fter implant then routinely every 3 to 6 months
nd as clinically indicated. If the echo is technically
ifficult despite echo contrast use, transesophageal
cho is usually performed when LVAD dysfunction is
uspected or in the presence of complications. Cardiac
T can be employed if there is persistent clinical
oncern for inflow/outflow graft thrombosis or mal-
osition in the setting of a nondiagnostic echo.
onclusions
chocardiography is the primary imaging modality to
etermine ventricular size and function, assess valvular
unction, and screen for pulmonary hypertension and
yocardial recovery in patients supported by LVADs.
nowledge of LVAD physiology, its effect on cardiac
unction, and potential complications is essential. In
omparison to echo, cardiac CT offers complete visu-
lization of the inflow and outflow cannulas and
nastomotic sites and can be helpful in detecting
evice-related thrombus, kinking, or malposition. We
ave described the application of echo for surgically
laced adult LVADs, and many of the same concepts
pply to percutaneous continuous-flow and pediatric
VADs. As newer generation continuous-flow
VADs gain widespread recognition with more long-
erm support anticipated, standardized echo image
cquisition, interpretation, and potentially multimo-
ality imaging will aid researchers and clinicians to
tudy, monitor, and care for this increasing patient
opulation.
eprint requests and correspondence: Dr. Jerry D. Estep,
he Methodist DeBakey Heart and Vascular Center,
mith Tower, 6550 Fannin Street, Suite 1901, Houston,
exas 77030. E-mail: jestep@tmhs.org.Figure 16. Imaging A
Extensive color DoppleTable 4. LVAD Echo Imaging and Reporting Protocol
1. Document standard demographics, annotate device type, device mode or pump speed setting (i.e., RPMs for continuous-ﬂow pumps; automatic or
ﬁxed rate for pulsatile pumps).
2. Standard comprehensive echo examination for any heart failure patient.
3. Parasternal long- and short-axis views: record 3 to 5 cardiac cycles, 2D and M-mode evaluation to assess ventricular dimensions/function and
qualitative AV opening frequency/duration.
4. Inﬂow cannula views (orientation can vary): use standard and off-axis 4- and 2-chamber apical views, parasternal long- (mid level) and apical parasternal
long-axis views (modiﬁed apical). Obtain 2D, color, and spectral Doppler from view with the best alignment. Report ﬂow characteristics (ﬂow direction,
turbulent versus nonturbulent ﬂow and peak velocity) to delineate normal from an obstructive or a reversal ﬂow pattern.
5. Outﬂow cannula views: right parasternal (low- and mid-level) view. Obtain 2D, color, and spectral Doppler and report ﬂow characteristics similar to the
inﬂow examination.
6. Outﬂow cannula-ascending aorta anastomosis view: right parasternal (low, mid, or higher level) view or sternal notch view. Obtain 2D, color, and spectral
Doppler.
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